Biotech company makes new discovery in hormone imbalance research

A biotech startup achieved a significant breakthrough in the development of therapies that seek to reverse age related hormone imbalances.

JangoBio, a Madison based startup, announced the breakthrough in a press release Feb. 18. The company successfully created organ-like tissue clusters capable of producing ovarian and testicular hormones.

University of Wisconsin endocrinology professor and JangoBio CEO Craig Atwood founded the company in 2014 to address limitations in the current approach to treating hormone imbalances that occur with age.

“As ovaries and testes start to decline in function there’s a loss of dozens of different hormones which are very important for maintaining tissue health,” Atwood said.

Read the full article at: